APA (7th ed.) Citation

Aftabi, H., & Aftabi, R. (2025). Effects of canagliflozin on cardiovascular disease risk factors in patients with type 2 diabetes: A systematic review and meta-analysis. BMC Endocrine Disorders, 25(1), 1. https://doi.org/10.1186/s12902-025-01984-3

Chicago Style (17th ed.) Citation

Aftabi, Hossein, and Reyhaneh Aftabi. "Effects of Canagliflozin on Cardiovascular Disease Risk Factors in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis." BMC Endocrine Disorders 25, no. 1 (2025): 1. https://doi.org/10.1186/s12902-025-01984-3.

MLA (9th ed.) Citation

Aftabi, Hossein, and Reyhaneh Aftabi. "Effects of Canagliflozin on Cardiovascular Disease Risk Factors in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis." BMC Endocrine Disorders, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12902-025-01984-3.